These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 31939034)

  • 41. Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer.
    Kim H; Heo MH; Kim JY
    BMC Gastroenterol; 2020 Jan; 20(1):20. PubMed ID: 31992208
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of sex in the outcomes of patients with biliary tract cancers remains unclear: A population-based study.
    Lemke M; DeWit Y; Nanji S; Booth CM; Flemming JA
    Am J Surg; 2018 Dec; 216(6):1118-1121. PubMed ID: 29934122
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Local salvage therapy for late (≥2 years) metastatic and local relapse of renal cell cancer is a potentially curative treatment irrespective of the site of recurrence.
    Grüllich C; Vallet S; Hecht C; Duensing S; Hadaschik B; Jäger D; Hohenfellner M; Pahernik S
    Urol Oncol; 2016 May; 34(5):238.e9-17. PubMed ID: 26739671
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison between autologous and homologous blood transfusions in liver resection for biliary tract cancer: a propensity score matching analysis.
    Onoe S; Yokoyama Y; Ebata T; Igami T; Mizuno T; Yamaguchi J; Watanabe N; Nagino M
    J Hepatobiliary Pancreat Sci; 2018 Dec; 25(12):550-559. PubMed ID: 30428161
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan Criteria.
    Kardashian A; Florman SS; Haydel B; Ruiz RM; Klintmalm GB; Lee DD; Taner CB; Aucejo F; Tevar AD; Humar A; Verna EC; Halazun KJ; Chapman WC; Vachharajani N; Hoteit M; Levine MH; Nguyen MH; Melcher ML; Langnas AN; Carney CA; Mobley C; Ghobrial M; Amundsen B; Markmann JF; Sudan DL; Jones CM; Berumen J; Hemming AW; Hong JC; Kim J; Zimmerman MA; Nydam TL; Rana A; Kueht ML; Fishbein TM; Markovic D; Busuttil RW; Agopian VG
    Hepatology; 2020 Dec; 72(6):2014-2028. PubMed ID: 32124453
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Variants in oxidative stress-related genes affect the chemosensitivity through Nrf2-mediated signaling pathway in biliary tract cancer.
    Zhan M; Wang H; Xu SW; Yang LH; Chen W; Zhao SX; Shen H; Liu Q; Yang RM; Wang J
    EBioMedicine; 2019 Oct; 48():143-160. PubMed ID: 31590928
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Elevated Serum Levels of CCL23 Are Associated with Poor Outcome after Resection of Biliary Tract Cancer.
    Roderburg C; Labuhn S; Bednarsch J; Lang SA; Schneider AT; Hammerich L; Vucur M; Ulmer TF; Neumann UP; Luedde T; Loosen SH
    Mediators Inflamm; 2022; 2022():6195004. PubMed ID: 36505756
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk factors for fatal recurrence of hepatocellular carcinoma and their role in selecting candidates for liver transplantation.
    Zou WL; Zang YJ; Chen XG; Shen ZY
    Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):145-51. PubMed ID: 18397848
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk factors and characteristics of young patients with the biliary tract carcinoma: results of a project study for biliary surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery.
    Ariake K; Unno M; Yoshida H; Kubo S; Horiguchi A; Yamaue H; Yamamoto M
    J Hepatobiliary Pancreat Sci; 2020 Sep; 27(9):571-580. PubMed ID: 32510820
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Significance of tumor necrosis for outcome of patients with hepatocellular carcinoma receiving locoregional therapy prior to liver transplantation.
    Chan KM; Yu MC; Chou HS; Wu TJ; Lee CF; Lee WC
    Ann Surg Oncol; 2011 Sep; 18(9):2638-46. PubMed ID: 21584831
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect on survival of local treatment in patients with low prostate-specific antigen, high Gleason score prostate cancer: a population-based propensity score-matched analysis.
    Liu S; Wang XY; Huang TB; Niu Q; Yao K; Song X; Zhou SY; Chen Z; Zhou GC
    Ann Palliat Med; 2020 Jul; 9(4):1708-1717. PubMed ID: 32527134
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatocholangiocarcinoma/intrahepatic cholangiocarcinoma: are they contraindication or indication for liver transplantation? A propensity score-matched analysis.
    Ma KW; Chok KSH; She WH; Cheung TT; Chan ACY; Dai WC; Fung JYY; Lo CM
    Hepatol Int; 2018 Mar; 12(2):167-173. PubMed ID: 29450868
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of intraluminal brachytherapy on survival outcome for radiation therapy for unresectable biliary tract cancer: a propensity-score matched-pair analysis.
    Yoshioka Y; Ogawa K; Oikawa H; Onishi H; Kanesaka N; Tamamoto T; Kosugi T; Hatano K; Kobayashi M; Ito Y; Takayama M; Takemoto M; Karasawa K; Nagakura H; Imai M; Kosaka Y; Yamazaki H; Isohashi F; Nemoto K; Nishimura Y;
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):822-9. PubMed ID: 24969796
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Operative salvage for locoregional recurrent colon cancer after curative resection: an analysis of 100 cases.
    Bowne WB; Lee B; Wong WD; Ben-Porat L; Shia J; Cohen AM; Enker WE; Guillem JG; Paty PB; Weiser MR
    Dis Colon Rectum; 2005 May; 48(5):897-909. PubMed ID: 15785892
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Outcome of liver transplantation for hepatocellular carcinoma -- a single center experience.
    Iacob R; Iacob S; Gheorghe L; Gheorghe C; Hrehoreţ D; Brașoveanu V; Croitoru A; Herlea V; Popescu I
    Chirurgia (Bucur); 2013; 108(4):446-50. PubMed ID: 23958083
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Completion of adjuvant S-1 chemotherapy after surgical resection for biliary tract cancer: A single center experience.
    Iwaki K; Yoh T; Nishino H; Nishio T; Koyama Y; Ogiso S; Ishii T; Kanai M; Hatano E
    Asian J Surg; 2024 Mar; 47(3):1383-1388. PubMed ID: 38160154
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic significance of the recurrence pattern and risk factors for recurrence in patients with proximal gastric cancer who underwent curative gastrectomy.
    Bilici A; Selcukbiricik F
    Tumour Biol; 2015 Aug; 36(8):6191-9. PubMed ID: 25761877
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American Series.
    Sapisochin G; Goldaracena N; Astete S; Laurence JM; Davidson D; Rafael E; Castells L; Sandroussi C; Bilbao I; Dopazo C; Grant DR; Lázaro JL; Caralt M; Ghanekar A; McGilvray ID; Lilly L; Cattral MS; Selzner M; Charco R; Greig PD
    Ann Surg Oncol; 2015 Jul; 22(7):2286-94. PubMed ID: 25472651
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Locoregional recurrence and survival after curative resection of adenocarcinoma of the colon.
    Read TE; Mutch MG; Chang BW; McNevin MS; Fleshman JW; Birnbaum EH; Fry RD; Caushaj PF; Kodner IJ
    J Am Coll Surg; 2002 Jul; 195(1):33-40. PubMed ID: 12113543
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The efficiency and regimen choice of adjuvant chemotherapy in biliary tract cancer: A STROBE-compliant retrospective cohort study.
    Yin L; Xu Q; Li J; Wei Q; Ying J
    Medicine (Baltimore); 2018 Dec; 97(50):e13570. PubMed ID: 30558021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.